Drugs / Autologous dendritic cells electroporated with WT1 mRNA
Autologous dendritic cells electroporated with WT1 mRNA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03083054 | Aug 2016 → Jul 2020 | acute myeloid leukemia, myelodysplastic syndrome | University of Campinas, Brazil | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous dendritic cells electroporated with WT1 mRNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03083054 ↗ |
| Modality | Cell therapy | “autologous dendritic cells vaccines” NCT03083054 ↗ |